No cure, no pay
The incentive structure shapes every decision made in an engagement
Aligned with the client's objectives
No retainer. No project fee for activity performed. Our compensation is aligned with the client’s commercial objective, not with the continuation of the process. Most China advisory models are paid for activity. Shaeps is paid for commercial outcomes. That is not a pricing distinction. It is a decision-making distinction.
The engagement level determines how much Shaeps does. The commercial outcome determines when Shaeps is paid.
Why time-based advisory is a problem
Activity-based billing creates predictable behaviour
Time-billing creates issues
The consequences are predictable. Projects at an uncertain stage are kept in motion rather than forced to a definitive assessment. No-go conclusions are softened or deferred. A clean exit recommendation terminates the engagement. Scope expands organically: additional research phases, new workstreams, extended timelines that increase billable time without necessarily increasing the probability of commercial success.
How no cure, no pay changes the engagement
The no-go conclusion becomes a legitimate output. Under a time-billed structure, recommending that a client does not proceed terminates the engagement. Under no-cure-no-pay, recommending no-go is still a loss - outcome compensation is not received - but the incentive structure no longer penalises the honest assessment.
Accurate judgement becomes commercially rational. Process continuation does not
What the model is not
Not free consulting
Not unlimited speculative work
Not success-at-any-cost
Not suitable for every company


